Comparison Between Long-Term Clinical Outcomes of Vitamin K Antagonist and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

CONCLUSIONS: Compared with DOACs, VKA with poorly controlled INR and antiplatelet agents correlated with adverse outcomes of death, MI, stroke, and TLR in patients undergoing PCI. PMID: 29863094 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29863094?dopt=Abstract

Source: Circulation Journal - June 1, 2018 Category: Cardiology Authors: Yoshida R, Morishima I, Takagi K, Morita Y, Tsuboi H, Murohara T Tags: Circ J Source Type: research